175 related articles for article (PubMed ID: 32831309)
1. A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties.
Calitz C; Pavlović N; Rosenquist J; Zagami C; Samanta A; Heindryckx F
J Vis Exp; 2020 Aug; (162):. PubMed ID: 32831309
[TBL] [Abstract][Full Text] [Related]
2. A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing.
Yip D; Cho CH
Biochem Biophys Res Commun; 2013 Apr; 433(3):327-32. PubMed ID: 23501105
[TBL] [Abstract][Full Text] [Related]
3. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
4. Influence of extracellular matrix composition on tumour cell behaviour in a biomimetic in vitro model for hepatocellular carcinoma.
Calitz C; Rosenquist J; Degerstedt O; Khaled J; Kopsida M; Fryknäs M; Lennernäs H; Samanta A; Heindryckx F
Sci Rep; 2023 Jan; 13(1):748. PubMed ID: 36639512
[TBL] [Abstract][Full Text] [Related]
5. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
Qu J; Zhao X; Ma PX; Guo B
Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
[TBL] [Abstract][Full Text] [Related]
6. Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma.
Al-Rawashdeh FY; Scriven P; Cameron IC; Vergani PV; Wyld L
Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1099-105. PubMed ID: 20177386
[TBL] [Abstract][Full Text] [Related]
7. Ready to go 3D? A semi-automated protocol for microwell spheroid arrays to increase scalability and throughput of 3D cell culture testing.
Basu A; Dydowiczová A; Trosko JE; Bláha L; Babica P
Toxicol Mech Methods; 2020 Oct; 30(8):590-604. PubMed ID: 32713235
[TBL] [Abstract][Full Text] [Related]
8. A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinoma.
Hou J; Hong Z; Feng F; Chai Y; Zhang Y; Jiang Q; Hu Y; Wu S; Wu Y; Gao X; Chen Q; Wan Y; Bi J; Zhang Z
BMC Cancer; 2017 Nov; 17(1):729. PubMed ID: 29117859
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
10. Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.
You ML; Chen YJ; Chong QY; Wu MM; Pandey V; Chen RM; Liu L; Ma L; Wu ZS; Zhu T; Lobie PE
Oncotarget; 2017 Jun; 8(24):39323-39344. PubMed ID: 28445151
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of the miR-325-3p/DPAGT1 axis supports HBV-positive HCC chemoresistance.
Li R; Xu T; Wang H; Wu N; Liu F; Jia X; Mi J; Lv J; Gao H
Biochem Biophys Res Commun; 2019 Nov; 519(2):358-365. PubMed ID: 31519321
[TBL] [Abstract][Full Text] [Related]
12. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
13. Modelling liver cancer microenvironment using a novel 3D culture system.
Al Hrout A; Cervantes-Gracia K; Chahwan R; Amin A
Sci Rep; 2022 May; 12(1):8003. PubMed ID: 35568708
[TBL] [Abstract][Full Text] [Related]
14. The study of establishment of an in vivo tumor model by three-dimensional cells culture systems methods and evaluation of antitumor effect of biotin-conjugated pullulan acetate nanoparticles.
Chen H; Wei X; Chen H; Wei H; Wang Y; Nan W; Zhang Q; Wen X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):123-131. PubMed ID: 30663429
[TBL] [Abstract][Full Text] [Related]
15. A novel platform for drug testing: Biomimetic three-dimensional hyaluronic acid-based scaffold seeded with human hepatocarcinoma cells.
Turtoi M; Anghelache M; Bucatariu SM; Deleanu M; Voicu G; Safciuc F; Manduteanu I; Fundueanu G; Simionescu M; Calin M
Int J Biol Macromol; 2021 Aug; 185():604-619. PubMed ID: 34216662
[TBL] [Abstract][Full Text] [Related]
16. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
Liu H; Chen W; Liang C; Chen BW; Zhi X; Zhang S; Zheng X; Bai X; Liang T
Cancer Lett; 2015 Jun; 361(2):218-25. PubMed ID: 25749422
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase 2 regulates the doxorubicin (Dox) resistance of hepatocarcinoma cells and transcription of ABCB1.
Yang Y; Zhang J; Wu T; Xu X; Cao G; Li H; Chen X
Life Sci; 2019 Jan; 216():200-206. PubMed ID: 30465789
[TBL] [Abstract][Full Text] [Related]
18. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
Wang C; Tong X; Yang F
Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
[TBL] [Abstract][Full Text] [Related]
19. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
20. Microporous cellulosic scaffold as a spheroid culture system modulates chemotherapeutic responses and stemness in hepatocellular carcinoma.
Wu G; Zhan S; Rui C; Sho E; Shi X; Ding Y
J Cell Biochem; 2019 Apr; 120(4):5244-5255. PubMed ID: 30302811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
